Our Team

Pat Dillon is the Founder, President and CEO of MNSBIR, Inc., a private, non-profit organization to support startups and small businesses to research, develop and commercialize technologies into novel products and services for domestic and global markets by leveraging federal research and development investments. Dillon has nearly 45 years of experience in government, industry, non-profit and academic organizations. Dillon is a leader in Minnesota’s innovation, investment, and commercialization ecosystem with nearly 30 years of knowledge, experience and relationships in the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.

Dillon is a member of the University of Minnesota (U of M), Technology Commercialization, Business Advisory Group; the Chair of the Advisory Board for the U of M, Technological Leadership Institute; a mentor for the Carlson School of Management, STARTUP Course; a frequent contributor to MN-REACH and MIN-CORPS (I-Corps Programs); a former MN-CUP Life Sciences Semi-Finalist Committee Member; a former speaker and moderator at the U of M Medical Devices Conference, Government Funding for Startups; and a frequent speaker at Twin Cities Startup Week, and taught a graduate course at the Mayo Clinic, Office of Entrepreneurship.

A staunch advocate of the SBIR/STTR programs, Dillon has tirelessly led the startup of MNSBIR in 2014 while at MEDA, then transitioning to Minnesota Technology Association (formerly the Minnesota High Technology Association) in 2016. Previously, Dillon served as the Northwest Regional Director for the Wisconsin Entrepreneurs Network from 2005-2013, a key initiative under Governor’s Doyle’s Grow Wisconsin plan. From 1992-2004, Dillon served in multiple roles at Minnesota Project Innovation, Inc. that culminated into the role of Executive Director in 2004. MPI, Inc. had a successful track record for 20 years before state budget challenges impacted its funding sources.

Dillon is a 1999 recipient of the prestigious Small Business Administration’s Tibbetts Award: a national award for excellence in the SBIR/STTR Programs. Pat is also a 2001 recipient of the City Business’ 25 Most Innovative Woman Award (now the Minneapolis/St. Paul Business Journal). Pat has served as a commercialization plan reviewer for the National Science Foundation (twice) and the United States Department of Agriculture (multiple times) and was the principal investigator of an Office of Naval Research contract for SBIR outreach in a five-state region for the first-ever SWIFT Tour (SBIR/STTR Where Innovation Focuses on Technology) (now called SBIR Road Tours).

Dillon is a retired United States Navy Commander with 40 years of service both active and reserve, and in both aviation and intelligence communities. Pat is a combat veteran having served 10 months in Kabul, Afghanistan in support of Operation Enduring Freedom. Dillon is a proud recipient of the Vietnam Era GI Bill earning an MBA and BS in Business Administration from Winona State University, Winona, MN.

Anja Metzger, PhD has 30 years of medical device experience with the most recent 20 years focused on cardiovascular medical devices and obtaining over 20MM dollars in non-diluted small business grant funding from the NIH and DoD SBIR and CDMRP programs to explore innovative technologies and bring them to market. She has written and served as PI or a co-investigator in over 30 Phase 1, Phase 2, and Phase 2+ grant applications to support product development, pre-clinical and clinical trials with an 80% original submission success rate. In addition to her experience in cardiovascular medical devices she has assisted several companies focused on devices for orthopedics, cancer, and other disease states. In 2012, during her tenure at Advanced Circulatory Systems, she received the SBA’s SBIR Tibbets award and was recognized as being in the top 25 NIH Grant Recipients in 2013.  She has extensive knowledge of pre-clinical, clinical, and product development strategies, the ability to bring theory into practice, and is recognized as a named inventor on over 30 U.S. patent applications. Work with multiple firms including Johnson & Johnson, Medtronic, and several start-up medical device companies has provided Anja an in-depth understanding of clinical, regulatory and quality aspects of the medical device business including risk assessment, the development of requirements and product specifications, design assurance, and pre-clinical and clinical design and execution. Anja has a Biomedical Engineering PhD from the University of Minnesota and a Bachelor of Arts in Chemistry from the College of St. Catherine. She is also an Adjunct Associate Professor in the University of Minnesota’s Emergency Medicine Department and is an author of over 40 publications. In her role as Founder and CEO of Innovative MN Medical Solutions, she provides consulting services for non-dilutive funding opportunities, focusing on NIH and DoD SBIR/STTR grant proposals for novel medical device technologies. Services include identification of specific grant opportunities, professional review and critique of proposals and applications, proposal editing, proposal writing and submission, pre-clinical and clinical study design/procurement assistance, proposal brainstorming and research strategy outline, and complete proposal preparation.

David Goldfeld is a polymer chemist/physicist specializing in materials engineering and innovation and entrepreneurship. David was previously the Chief Technology Officer at Phoam Labs, a University of Minnesota spin-off company commercializing compostable foam technology he patented while in graduate school. As CTO, he carried their first product to market and won a variety of awards, including the grand prize in the 2022 Minnesota Cup.

David has worked in a variety of industries, including pharmaceuticals, inorganic nanoparticles, semiconductor manufacturing, organic polymer synthesis, sustainable materials, and membrane technologies. He has extensive experience in grant-writing submissions to agencies including NSF, DOE, and USDA, and worked for years in scientific communication, overseeing social media channels, websites, public and internal reports, and fundraising materials.

He has authored more than a dozen academic papers published during his time at six different universities and two national laboratories with more than 800 citations. David has a B.A. in Physics and a B.S. in Chemistry from the University of Chicago and an M.S. and Ph.D. in Chemistry from the University of Minnesota.

Diane Rucker is an angel investor and an active mentor in Minnesota’s growing entrepreneurial ecosystem. She recently stepped down as the Executive Director of University Enterprise Laboratories (UEL), a business incubator for early stage ventures in biotechnology, healthcare, medical health, and life sciences. Diane has an Executive MBA from the MIT Sloan School of Management, and served as a mentor and judge for the MIT 100K competition. She also has an M.S. in Materials Science and Engineering from the University of Michigan, and an SB in Materials Science and Engineering from the Massachusetts Institute of Technology. Her recent experience includes a collaboration with MIT’s Trust Center for Entrepreneurship and broad – based business and ecosystem experience around the world, including Europe, Asia, and the Middle East. She served as the VP of Client Services for Carrot Health, a startup in healthcare analytics (acquired by UniteUs), and held leadership roles with Seagate and General Motors.

Diane serves on several boards, including the gener8tor gBETA Advisory Board. Diane invests in seed-stage funds with a focus on Minnesota and Midwest startups and on underrepresented founders, She is an LP in Groove Capital, Tundra Ventures, Bread and Butter Ventures, gener8tor, and Great North Ventures. She and her husband, Derek, live in Apple Valley, Minnesota, with their three (awesome) daughters.

Jim Stice, currently a principal with MedCelleration, a Minnesota consulting firm providing medical device IP scouting, project assessment and management services, including non-dilutive SBIR funding assistance with preparation of grant submissions, which involves advising multiple medical device customers on NIH SBIR Phase I and II strategy, IP scouting focused on medical device specialties identifying and assessing inventions fitting a search profile. Management services cover SBIR grant submissions and award execution. Over the last year, MedCelleration clients have obtained a total of $12M in NIH SBIR/STTR awards.

Prior to MedCelleration, Jim led Twin Star Medical, a medical device company providing drug delivery and acute trauma products to researchers and physicians that pioneered the use of porous device platform for multiple indications with non-dilutive funding, leveraging private equity ten times with over $20 million in Federal R&D grants during 10 years, securing four 510K clearances and two IDE approvals, implementing four IRB approved pilot clinical studies, and obtained ten patents for porous medical device platform. During his career, Jim also helped launch other medical device and healthcare startups as founder and/or Board member in addition to serving as Chairman of Medical Alley.

Intercepting Horizons provides research and advice to boards and C-suites on sustainable profitable growth strategies that encompass organic expansion and M&A with a specific focus on perceived value enhancement. With a deep understanding of the impact of emerging and converging technologies, we help organizations stay ahead of the curve and succeed in rapidly changing markets.

​Our unique value proposition lies in advising companies and organizations on the direction and timing of strategic decisions, recognizing that intercepting convergences on the horizon is key to capturing opportunities. From start-ups to global mid-caps, we leverage years of board, C-suite, and entrepreneurial experience to assist our clients in navigating change.

Susan Henken-Thielen is a senior level product and marketing expert with 40 years of executive experience in a range of industries including educational and medical technology and devices, consumer goods, fitness, and higher education.  Her career has focused on developing and introducing innovative, impactful and beneficial products, services and businesses that uniquely meet the needs of target customers.  As the president of a product launch and marketing consulting business, she provides strategic assistance to entrepreneurial ventures, mid-sized and Fortune 500 companies, non-profit organizations, and higher education institutions, providing marketing research insights, product optimization, market development and enhancement strategies, and marketing plans that launch new and grow existing businesses.

Previous experience includes leading product strategy, product development and management initiatives for Collegis Education, a higher education consulting company. Prior to joining Collegis Education, she led the product, marketing and project management for the development and implementation of the online Competency-Based Learning initiative at Rasmussen University. As an Adjunct Professor for Rasmussen University, she taught marketing, sales and consumer behavior classes.  Serving as Brand Director on several new ventures at Pearsom Vue, she led product launches and marketing strategies for new higher education assessment software businesses globally, marketed to businesses and consumers, establishing the UExcel® brand as one of the leaders in the competency-based higher education assessment industry. Susan has also held Marketing and Product Management leadership positions at the US subsidiary of Irish medical device company Bio-Medical Research, Ltd., Compex Technologies, and Cigna Behavioral Care.

Susan is an active volunteer, currently serving as Vice President on the Board of Minnesota Lakes and Rivers Advocates, an advocacy group focused on protecting Minnesota waters from pollution, over-development and Aquatic Invasive Species. She also served for 7 years on the select Grinnell College Alumni Council, an alumni leadership organization, where she held the role of President.  Susan earned her Master of Management degree at the Kellogg School, Northwestern University, Evanston, IL, with concentrations in Marketing, Strategy, and Industrial Relations. She graduated from Grinnell College, Grinnell, IA with a B.A. in Psychology, with highest honors, and earned membership in the Grinnell and Mortar Board Honor Societies and Phi Beta Kappa. In 2019, she was honored with a Grinnell College Alumni Award for accomplishments and contributions in her career, community and to the College.

Tamara Bratland expertise is commercializing medical devices globally.  She works with medical device startups on creating strong strategies, executable marketing plans, relevant value propositions with a path to product commercialization.  Currently, she is working with numerous start-up companies as consultant, founder, marketing leader or mentor, defining product concepts and commercialization approaches.  Recent projects have been with the University of Minnesota, Technology Commercialization Office, and the National Institute of Health, Technical and Business Assistance programs. She brings over 30 years of experience in medical devices and high tech, with leadership roles in marketing and product development at Medtronic and Honeywell.  She has an MBA and Bachelor of Science in Electrical Engineering, is a certified Project Management Professional and holds 7 US Patents.

Jeff Carpenter, PhD, principal of Bird Dog Innovation Strategies, specializes in SBIR TABA commercialization assistance. Services include customer discovery, articulation of value proposition, market sizing, competitive assessment, go-to-market strategy, patent strategy, monetization of patents through licensing, and fundraising strategy. Bird Dog has worked with dozens of SBIR grantees in a wide range of industry sectors, including life sciences, clean technology, agriculture, food, materials and chemicals. Jeff assists with Phase I commercialization plan development to optimize preparation for Phase II, and also provides TABA services during Phase II, to help companies in their transition from research to commercialization. Jeff holds BS and MS Degrees in Rangeland Ecology from the University of Montana, a PhD in Genetics and Cell Biology from the University of Minnesota, and is a Certified Licensing Professional.